Biotop-report 2014

43

BioTOPics 47 | May 2014 

BioTOP-Report

 Addresses

Pharmaceutical Companies

BERLIN-CHEMIE 

Aktiengesellschaft

BERLIN-CHEMIE is a German subsidiary of  the MENARINI Group. The company, 

which was formed in 1886 and is headquartered in Florence, was developed over 

the generations to become a global, owner-managed pharmaceutical company. Re-

search is centred on the development of  innovative drugs for the following areas: 

inflammatory diseases and pain, cardiovascular diseases, oncology, viral disease. 

berlin-chemie.de

Chemisch-pharmazeutisches 

Labor, Rolf Sachse GmbH

CPL S: Custom synthesis development of  active pharmaceutical ingredients (API’s), 

Contract manufacture of  active pharmaceutical ingredients from laboratory to kilo-

scale, Pharmaceutical analysis.

cpl-sachse.de

Daiichi Sankyo

Daiichi Sankyo is a global pharmaceutical company with corporate origins in Japan. 

We provide innovative products and services in more than 50 countries around the 

world. With more than 100 years of  scientific expertise, our company draws upon 

a rich legacy of  innovation and a robust pipeline of  promising new medicines to 

help patients. Through the outstanding knowledge and commitment of  our 30,000 

employees worldwide, we create innovative new and generic medicines, and new 

methods of  drug discovery and delivery. We share a passion for innovation, as well 

as compassion for the patients around the world who are in need of  our medicines.

daiichisankyo.com

Dr. Kade Pharmazeutische Fabrik 

GmbH

The company’s activities concentrate on the production and marketing of  drugs in 

the fields of  gynecology, proctology, pain relief/ rheumatism and urology. The poten-

tial of  proven drugs is expanded systematically by galenic developments to produce 

innovative products.

kade.de

Haupt Pharma AG

With ,nine production sites Haupt Pharma is one of  the leading contract man-

ufacturers for pharmaceutical products in ,the world ,today. ,About 

2.000 ,employees produce for an established clientele of  more than 200 im-

portant international pharmaceutical companies, amongst which 15 of  the interna-

tional TOP 25. 

haupt-pharma.de

Heyl chemisch pharmazeutische 

Fabrik GmbH & Co. KG

HEYL is an independent, entrepreneurial family business that has its headquarters in 

probably the liveliest German metropolis, Berlin, since its establishment in 1926. In 

cooperation with our international subsidiaries, the main focuses of  our work are the 

Regulatory Affairs and marketing of  medicines as well as the sale of  active pharma-

ceutical ingredients (API's) and special chemicals. 

heyl-berlin.com

Klosterfrau Berlin GmbH

For more than 175 years Klosterfrau has been developing, manufacturing and mar-

keting pharmaceutical products. The profile of  traditional yet modern natural med-

icines has grown significantly in recent times. Based on the latest scientific discov-

eries combined with the development of  new markets, the range is constantly being 

expanded with innovative products. 

klosterfrau.de

medphano Arzneimittel GmbH

medphano Arzneimittel in Rüdersdorf  stands for proven and cost-effective phar-

maceutical preparations. Main products are analgesics/anti-rheumatics, antibiotics, 

dermatics, diuretics, drugs to stimulate blood circulation, drugs for treatment of  gas-

tro-intestinal disorders, vitamins, expectorants, lipid-lowering agents, ophthalmics, 

cosmetics, food supplements, diet foods and foods. 

medphano.de

MUCOS Pharma GmbH & Co.KG

As a specialist in enzyme preparations Mucos supplies a steadily growing market 

with specific and variably dosed enzyme combinations. The company leads the 

world market in oral enzymes for therapeutic purposes. 

mucos.de

Pfizer Pharma GmbH

Pfizer is the world's largest research-based biomedical and pharmaceutical com-

pany.

pfizer.de

Pharma Action GmbH

Pharma Action has extensive expertise in global pharmaceutical marketing and man-

ufacturing since 1988 and offers cutting edge API solutions to the pharmaceutical 

industry in Europe and abroad. 

pharma-action.com

PharmaMar GmbH

PharmaMar is a biopharmaceutical subsidiary of  Grupo Zeltia; it is a world leader in 

discovering, developing and marketing marine-based drugs to treat cancer. Yondel-

is

®

 is the first marine-based antitumour drug. PharmaMar has four other compounds 

in clinical development: Aplidin

®

, Zalypsis

®

, PM01183 and PM060184. PharmaMar 

also has a rich pipeline of  pre-clinical candidates and a major R&D programme. 

PharmaMar GmbH, the German subsidiary, was officially established in November 

2013 in Berlin.

pharmamar.com

Piramal Imaging GmbH

Piramal Imaging is a start-up business within the Life-Science division of  the Mum-

bai-based Piramal Enterprises Group. The company is dedicated to the clinical re-

search & development and the global commercialization of  Nuclear Medicine / Mo-

lecular Imaging products for detection, characterization and monitoring of  disabling 

and life-threatening diseases in neurology, oncology and the cardio-vascular space.

imaging.piramalenterprises.

com

Sanofi-Aventis Deutschland 

GmbH

Sanofi-aventis is a leading global pharmaceutical company based in Paris and oper-

ating in over 100 countries. R&,D teams work on a global approach to patients, 

offering innovative therapeutic strategies in thrombosis, cardiovascular diseases, 

diabetes, vaccines, oncology, the central nervous system disorders and internal 

medicine.

sanofi-aventis.de

Shire Deutschland GmbH

Shire’s strategic goal is to become the leading specialty biopharmaceutical compa-

ny that focuses on meeting the needs of  the specialist physician. Shire focuses its 

business on attention deficit and hyperactivity disorder, human genetic therapies and 

gastrointestinal diseases. 

shire.de

---